Patient Centricity

The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality

Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand greater transparency, the pharmaceutical industry is undergoing a profound transformation in terms of patient centricity. Our latest white paper, “The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality,” explores how patient centricity has shifted from…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Patient centricity in pharma

The Evolving State of Patient Centricity in the Pharmaceutical Industry

Patient centricity has been a point of discussion in pharma for years. Learn what patient...
Racial and Ethnic Diversity in Pharma and Clinical Trials

Racial and Ethnic Diversity in Pharma and Clinical Trials

CACTUS strongly supports inclusion and diversity and is working hard to raise awareness about this...
DE&I Infographic #1

The Business Case for Diversity, Equity, and Inclusion (DE&I) in the Pharma Industry

To learn how much businesses can gain from more diverse and inclusive workplaces and why...
Plain Language Clinical Trial Summaries

Why Do Plain Language Clinical Trial Summaries Matter?

Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Leveraging technology for patient centricity

Leveraging Technology to Enhance Customer Experience – A 3-Pronged Approach for Medical Affairs

As digital technology changes everything from how drugs are discovered to how healthcare is delivered...
MSL-KOL relationship

Reimagining the MSL-KOL Relationship

MSL-KOL relationships: Medical Affairs teams and KOLs believe that approximately 40-50% of future interactions will...

Learn more ABOUT our company.